Adma Biologics (ADMA) Cash from Operations Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) Cash from Operations Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
89.73% |
| Date | Value |
|---|
| Dec 31, 2025 |
89.73% |
| Sep 30, 2025 |
44.23% |
| Jun 30, 2025 |
53.93% |
| Mar 31, 2025 |
8.89% |
| Dec 31, 2024 |
51.84% |
| Sep 30, 2024 |
56.95% |
| Jun 30, 2024 |
50.59% |
| Mar 31, 2024 |
59.44% |
| Dec 31, 2023 |
36.55% |
| Sep 30, 2023 |
35.77% |
| Jun 30, 2023 |
34.22% |
| Mar 31, 2023 |
15.78% |
| Dec 31, 2022 |
27.86% |
| Sep 30, 2022 |
17.47% |
| Jun 30, 2022 |
11.68% |
| Mar 31, 2022 |
-22.11% |
| Dec 31, 2021 |
-21.21% |
| Sep 30, 2021 |
-2.26% |
| Jun 30, 2021 |
-29.35% |
| Mar 31, 2021 |
-26.45% |
